1. The Korean External Eye Disease Society. Cornea. 2nd ed.Ilchokak;2005. p. 127–70.
2. Lee HJ, Kim SY, Jung MS. The clinical characteristics of facial herpes zoster in Korean patients. J Korean Ophthalmol Soc. 2010; 51:8–13.
Article
3. Lee HR, Cho BC. A clinical study of herpes zoster ophthalmicus. J Korean Ophthalmol Soc. 1988; 29:387–91.
4. Kim JY, Ahn M, Lee DW. Two cases of optic neuritis in herpes zoster ophthalmicus. J Korean Ophthalmol Soc. 2008; 49:1028–32.
Article
5. Zaal MJ, Völker-Dieben HJ, D'Amaro J. Visual prognosis in immunocompetent patients with herpes zoster ophthalmicus. Acta Ophthalmol Scand. 2003; 81:216–20.
Article
6. Park SH, Kim WJ, Yang SW, Kim MS. Herpes zoster ophthalmicus complicated by hyphema, glaucoma and external ophthalmoplegia. J Korean Ophthalmol Soc. 2007; 48:1573–8.
Article
7. Wang TJ, Hu CC, Lin HC. Increased risk of anterior uveitis following herpes zoster: a nationwide population-based study. Arch Ophthalmol. 2012; 130:451–5.
8. Bjerrum SS, Hessellund A. [Complete ophthalmoplegia following outburst of herpes zoster]. Ugeskr Laeger. 2012; 174:1832–3.
9. Hesse RJ. Herpes zoster ophthalmicus associated with delayed retinal thrombophlebitis. Am J Ophthalmol. 1977; 84:329–31.
Article
10. Borruat FX, Herbort CP. Herpes zoster ophthalmicus. Anterior ischemic optic neuropathy and acyclovir. J Clin Neuroophthalmol. 1992; 12:37–40.
11. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008; 115((2 Suppl)):S3–12.
12. Lexa FJ, Galetta SL, Yousem DM, et al. Herpes zoster ophthalmicus with orbital pseudotumor syndrome complicated by optic nerve infarction and cerebral granulomatous angiitis: MRpathologic correlation. AJNR Am J Neuroradiol. 1993; 14:185–90.
13. Beck RW, Trobe JD. The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group. J Neuroophthalmol. 1995; 15:131–5.
Article
14. Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994; 330:896–900.
Article